BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29249638)

  • 1. Androgen receptor overexpression in prostate cancer in type 2 diabetes.
    Lutz SZ; Hennenlotter J; Scharpf MO; Sailer C; Fritsche L; Schmid V; Kantartzis K; Wagner R; Lehmann R; Berti L; Peter A; Staiger H; Fritsche A; Fend F; Todenhöfer T; Stenzl A; Häring HU; Heni M
    Mol Metab; 2018 Feb; 8():158-166. PubMed ID: 29249638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin signaling, androgen receptor and PSMA immunohistochemical analysis by semi-automated tissue microarray in prostate cancer with diabetes (DIAMOND study).
    Broggi G; Lo Giudice A; Di Mauro M; Pricoco E; Piombino E; Ferro M; Caltabiano R; Morgia G; Russo GI
    Transl Res; 2021 Dec; 238():25-35. PubMed ID: 34314871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.
    Ben Jemaa A; Sallami S; Céraline J; Oueslati R
    Cell Biol Int; 2013 May; 37(5):464-70. PubMed ID: 23418075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen.
    Evans MJ; Smith-Jones PM; Wongvipat J; Navarro V; Kim S; Bander NH; Larson SM; Sawyers CL
    Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9578-82. PubMed ID: 21606347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: implications for PSA surrogacy.
    Kuroda K; Liu H; Kim S; Guo M; Navarro V; Bander NH
    Prostate; 2009 Oct; 69(14):1579-85. PubMed ID: 19575420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer Cells.
    Sommer U; Siciliano T; Ebersbach C; Beier AK; Stope MB; Jöhrens K; Baretton GB; Borkowetz A; Thomas C; Erb HHH
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA.
    Kristiansen I; Stephan C; Jung K; Dietel M; Rieger A; Tolkach Y; Kristiansen G
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin receptor isoforms A and B as well as insulin receptor substrates-1 and -2 are differentially expressed in prostate cancer.
    Heni M; Hennenlotter J; Scharpf M; Lutz SZ; Schwentner C; Todenhöfer T; Schilling D; Kühs U; Gerber V; Machicao F; Staiger H; Häring HU; Stenzl A
    PLoS One; 2012; 7(12):e50953. PubMed ID: 23251408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p,p'-Dichlorodiphenyltrichloroethane (p,p'-DDT) and p,p'-dichlorodiphenyldichloroethylene (p,p'-DDE) repress prostate specific antigen levels in human prostate cancer cell lines.
    Wong LI; Labrecque MP; Ibuki N; Cox ME; Elliott JE; Beischlag TV
    Chem Biol Interact; 2015 Mar; 230():40-9. PubMed ID: 25682698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells.
    Liu X; Choi RY; Jawad SM; Arnold JT
    Prostate; 2011 May; 71(7):766-77. PubMed ID: 21031436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of insulin-like growth factor-I receptor gene expression by wild type and mutant androgen receptor in prostate cancer cells.
    Schayek H; Seti H; Greenberg NM; Sun S; Werner H; Plymate SR
    Mol Cell Endocrinol; 2010 Jul; 323(2):239-45. PubMed ID: 20417685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner.
    Schayek H; Haugk K; Sun S; True LD; Plymate SR; Werner H
    Clin Cancer Res; 2009 Mar; 15(5):1558-65. PubMed ID: 19223505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
    Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
    Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks.
    Barfeld SJ; Urbanucci A; Itkonen HM; Fazli L; Hicks JL; Thiede B; Rennie PS; Yegnasubramanian S; DeMarzo AM; Mills IG
    EBioMedicine; 2017 Apr; 18():83-93. PubMed ID: 28412251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
    Wu JD; Haugk K; Woodke L; Nelson P; Coleman I; Plymate SR
    J Cell Biochem; 2006 Oct; 99(2):392-401. PubMed ID: 16639715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CYP7B1-related steroids on androgen receptor activation in different cell lines.
    Lundqvist J; Norlin M
    Biochim Biophys Acta; 2012 Jul; 1821(7):973-9. PubMed ID: 22484622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ad5/35E1aPSESE4: A novel approach to marking circulating prostate tumor cells with a replication competent adenovirus controlled by PSA/PSMA transcription regulatory elements.
    Hwang JE; Joung JY; Shin SP; Choi MK; Kim JE; Kim YH; Park WS; Lee SJ; Lee KH
    Cancer Lett; 2016 Mar; 372(1):57-64. PubMed ID: 26723876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate.
    Alinezhad S; Väänänen RM; Ochoa NT; Vertosick EA; Bjartell A; Boström PJ; Taimen P; Pettersson K
    BMC Urol; 2016 Feb; 16():10. PubMed ID: 26928323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.